Medications

Antimalarial drug no better than standard coronavirus care: study

Hydroxychloroquine, an antimalarial drug dubbed a "gift from God" by US President Donald Trump for its potential ability to fight the new coronavirus, was found to be no more effective than standard treatment in a small Chinese ...

Diseases, Conditions, Syndromes

Why the coronavirus and most other viruses have no cure

People hospitalized with severe symptoms from the coronavirus are given medicine to bring down the fever and fluids to keep them hydrated, generally by intravenous tube. Some patients are connected to a ventilator: a mechanical ...

Medical research

S1P and its receptor: New approaches to cancer?

In 1998, when Timothy Hla, Ph.D., and his colleagues identified and cloned the receptor for sphingosine-1-phosphate (S1P), it generated a lot of excitement. S1P, a lipid originally discovered in the 1960s, was known to play ...

Medications

Is it time to nationalize the drug industry?

Critics of the pharmaceutical industry say it is misaligned with public interest. So is it time to nationalise the sector? Experts debate the issue in The BMJ today.

Pediatrics

Coronavirus treatment and risk to breastfeeding women

Little data is available about the ability of antiviral drugs used to treat COVID-19, coronavirus, to enter breastmilk, let alone the potential adverse effects on breastfeeding infants. A new perspective article reviewing ...

Medications

US reports first drug shortage tied to virus outbreak

Health officials reported the first U.S. drug shortage tied to the viral outbreak that is disrupting production in China, but they declined to identify the manufacturer or the product.

Medications

Public opinion of drugs effectiveness may be too biased

People asked by experts to comment on the effectiveness of new psychiatric drug treatments appear to be unfairly biased even though they declare a conflict of interest, suggests research published online in the journal BMJ ...

page 25 from 40